These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
470 related articles for article (PubMed ID: 23188072)
1. Liver transplantation for hepatocellular carcinoma recurrence after liver resection: why deny this chance of cure? De Carlis L; Di Sandro S; Giacomoni A; Mangoni I; Lauterio A; Mihaylov P; Cusumano C; Rampoldi A J Clin Gastroenterol; 2013 Apr; 47(4):352-8. PubMed ID: 23188072 [TBL] [Abstract][Full Text] [Related]
2. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy? Adam R; Azoulay D; Castaing D; Eshkenazy R; Pascal G; Hashizume K; Samuel D; Bismuth H Ann Surg; 2003 Oct; 238(4):508-18; discussion 518-9. PubMed ID: 14530722 [TBL] [Abstract][Full Text] [Related]
3. Liver transplantation versus liver resection for the treatment of hepatocellular carcinoma. Lee KK; Kim DG; Moon IS; Lee MD; Park JH J Surg Oncol; 2010 Jan; 101(1):47-53. PubMed ID: 19798686 [TBL] [Abstract][Full Text] [Related]
4. Primary versus salvage living donor liver transplantation for patients with hepatocellular carcinoma: impact of microvascular invasion on survival. Moon JI; Kwon CH; Joh JW; Choi GS; Jung GO; Kim JM; Shin M; Choi SJ; Kim SJ; Lee SK Transplant Proc; 2012 Mar; 44(2):487-93. PubMed ID: 22410053 [TBL] [Abstract][Full Text] [Related]
5. Benefit of initial resection of hepatocellular carcinoma followed by transplantation in case of recurrence: an intention-to-treat analysis. Fuks D; Dokmak S; Paradis V; Diouf M; Durand F; Belghiti J Hepatology; 2012 Jan; 55(1):132-40. PubMed ID: 21932387 [TBL] [Abstract][Full Text] [Related]
6. Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation. Margarit C; Escartín A; Castells L; Vargas V; Allende E; Bilbao I Liver Transpl; 2005 Oct; 11(10):1242-51. PubMed ID: 16184539 [TBL] [Abstract][Full Text] [Related]
7. Treatment strategy for recurrent hepatocellular carcinoma: salvage transplantation, repeated resection, or radiofrequency ablation? Chan AC; Chan SC; Chok KS; Cheung TT; Chiu DW; Poon RT; Fan ST; Lo CM Liver Transpl; 2013 Apr; 19(4):411-9. PubMed ID: 23447460 [TBL] [Abstract][Full Text] [Related]
8. Time of hepatocellular carcinoma recurrence after liver resection and alpha-fetoprotein are important prognostic factors for salvage liver transplantation. Lee S; Hyuck David Kwon C; Man Kim J; Joh JW; Woon Paik S; Kim BW; Wang HJ; Lee KW; Suh KS; Lee SK Liver Transpl; 2014 Sep; 20(9):1057-63. PubMed ID: 24862741 [TBL] [Abstract][Full Text] [Related]
9. Living-donor liver transplantation associated with higher incidence of hepatocellular carcinoma recurrence than deceased-donor liver transplantation. Park MS; Lee KW; Suh SW; You T; Choi Y; Kim H; Hong G; Yi NJ; Kwon CH; Joh JW; Lee SK; Suh KS Transplantation; 2014 Jan; 97(1):71-7. PubMed ID: 24056623 [TBL] [Abstract][Full Text] [Related]
10. Single HCC in cirrhotic patients: liver resection or liver transplantation? Long-term outcome according to an intention-to-treat basis. Sapisochin G; Castells L; Dopazo C; Bilbao I; Minguez B; Lázaro JL; Allende H; Balsells J; Caralt M; Charco R Ann Surg Oncol; 2013 Apr; 20(4):1194-202. PubMed ID: 22965574 [TBL] [Abstract][Full Text] [Related]
11. Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation. Facciuto ME; Koneru B; Rocca JP; Wolf DC; Kim-Schluger L; Visintainer P; Klein KM; Chun H; Marvin M; Rozenblit G; Rodriguez-Davalos M; Sheiner PA Ann Surg Oncol; 2008 May; 15(5):1383-91. PubMed ID: 18320284 [TBL] [Abstract][Full Text] [Related]
12. Results of salvage liver transplantation. Guerrini GP; Gerunda GE; Montalti R; Ballarin R; Cautero N; De Ruvo N; Spaggiari M; Di Benedetto F Liver Int; 2014 Jul; 34(6):e96-e104. PubMed ID: 24517642 [TBL] [Abstract][Full Text] [Related]
13. Recurrence of hepatocellular cancer after liver transplantation: the role of primary resection and salvage transplantation in East and West. Lai Q; Avolio AW; Lerut J; Singh G; Chan SC; Berloco PB; Tisone G; Agnes S; Chok KS; Sharr W; Rossi M; Manzia TM; Lo CM J Hepatol; 2012 Nov; 57(5):974-9. PubMed ID: 22771712 [TBL] [Abstract][Full Text] [Related]
14. Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation. Cherqui D; Laurent A; Mocellin N; Tayar C; Luciani A; Van Nhieu JT; Decaens T; Hurtova M; Memeo R; Mallat A; Duvoux C Ann Surg; 2009 Nov; 250(5):738-46. PubMed ID: 19801927 [TBL] [Abstract][Full Text] [Related]
15. Serum C-reactive protein is a useful biomarker for predicting outcomes after liver transplantation in patients with hepatocellular carcinoma. An HJ; Jang JW; Bae SH; Choi JY; Yoon SK; Lee MA; You YK; Kim DG; Jung ES Liver Transpl; 2012 Dec; 18(12):1406-14. PubMed ID: 22821639 [TBL] [Abstract][Full Text] [Related]
16. Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes. Shah SA; Cleary SP; Wei AC; Yang I; Taylor BR; Hemming AW; Langer B; Grant DR; Greig PD; Gallinger S Surgery; 2007 Mar; 141(3):330-9. PubMed ID: 17349844 [TBL] [Abstract][Full Text] [Related]
17. Resection prior to liver transplantation for hepatocellular carcinoma. Belghiti J; Cortes A; Abdalla EK; Régimbeau JM; Prakash K; Durand F; Sommacale D; Dondero F; Lesurtel M; Sauvanet A; Farges O; Kianmanesh R Ann Surg; 2003 Dec; 238(6):885-92; discussion 892-3. PubMed ID: 14631225 [TBL] [Abstract][Full Text] [Related]
18. Living donor liver transplantation for hepatocellular carcinoma. Isik B; Ince V; Karabulut K; Kayaalp C; Yilmaz S Transplant Proc; 2012; 44(6):1713-6. PubMed ID: 22841251 [TBL] [Abstract][Full Text] [Related]
19. Longterm prognosis after hepatic resection for small hepatocellular carcinoma. Shimozawa N; Hanazaki K J Am Coll Surg; 2004 Mar; 198(3):356-65. PubMed ID: 14992736 [TBL] [Abstract][Full Text] [Related]
20. Infection with hepatitis C virus is an adverse prognostic factor after liver resection for early-stage hepatocellular carcinoma: implications for the management of hepatocellular carcinoma eligible for liver transplantation. Chirica M; Tranchart H; Tan V; Faron M; Balladur P; Paye F Ann Surg Oncol; 2013 Jul; 20(7):2405-12. PubMed ID: 23338483 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]